Resistance to Ibritumomab in Lymphoma

Springer Nature Switzerland AG, 2019

121,95 €On orderDelivery: 2-3 weeks

This volume, in discussing resistance to ibritumomab, will focus on the mechanism, hematological aspects, radiological and nuclear medicine aspects, and medical physics that deal with radiation dosimetry, and will outline future prospects for overcoming resistance and enhancing efficacy of ibritumomab.

ISBN-13
9783030086527
ISBN-10
3030086526
Publisher
Springer Nature Switzerland AG
Year
2019
Publication date
2019-01-08
Pages
158
Dimensions
235x155x